| 000 | 01901cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030835.0 | ||
| 008 | 130528s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.05.Ph.D.2013.Sa.R | ||
| 100 | 0 | _aSamah Hassan Abdo Elkhiat | |
| 245 | 1 | 0 |
_aRisk adapted therapy of childhood malignant germ cell tumors / _cSamah Hassan Abdo Elkhiat ; Supervised Lobna M. Elamin Shalaby , Ahmed Morsy M. Fahmy , Sahar Ahmed Khaleel |
| 246 | 1 | 5 | _aالعلاج طبقا لدرجة الخطورة للأطفال المصابين بسرطان الخلايا الجنينية |
| 260 |
_aCairo : _bSamah Hassan Abdo Elkhiat , _c2013 |
||
| 300 |
_a125P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology | ||
| 520 | _aTo evaluate risk adapted treatment protocol in children with malignant extracranial germ cell tumors ( GCTs ) in both the NCI and CCHE . Malignant GCTs in children aged 0 to 18 years were excised without major morbidity or otherwise biopsied . Stage I testicular and ovarian GCTs were resected and monitored ( " watch - wait " approach ) . Patients with recurrent stage I disease , stage II - IV testicular , stage II & III ovarian and stage I & II extragonadal received compressed PEB 3 cycles and continued according to evaluation after | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aExtracranial | |
| 653 | 4 | _aGerm cell tumor | |
| 653 | 4 | _aRisk adapted treatment | |
| 700 | 0 |
_aAhmed Morsy Mostafa Fahmy , _eSupervisor |
|
| 700 | 0 |
_aLobna Mohamed Elamin Shalaby , _eSupervisor |
|
| 700 | 0 |
_aSahar Ahmed Khaleel , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c43056 _d43056 |
||